Vision of Professor Fregni
American-Brazilian physician-scientist Felipe Fregni, MD, PhD, MPH and recipient of more than 360 PubMed citations, is director of the highly productive Spaulding-Labuschagne Neuromodulation Center. This lab is staffed by more than 50 people—over half with an MD or PhD terminal degree—who are involved in studying neuroplasticity and are at the forefront of advancing neurorehabilitation science to treat conditions such as stroke, depression, and chronic pain.
Professor Fregni and his colleagues have published more than 200 studies on transcranial direct-current stimulation (tDCS). His work with this low dose noninvasive electrical brain stimulation was featured in a New York Times article titled “Jumper Cables for the Mind” following a landmark study that he and colleagues published in JAMA Psychiatry that demonstrated that either Zoloft or tDCS equally improved depression, but when used together, there was a larger, synergistic effect.
Professor Fregni’s passion for discovering how the brain works is matched by his desire to teach others to pursue research. Perhaps fueled by a PhD in philosophy, Fregni is committed to teaching physicians how to conduct clinical trials. For more than twelve years, he has directed “Principles and Practice of Clinical Research”, an annual 9-month intensive international distance-learning course. More than 2,000 participants from over 30 countries have completed the training. Fregni believes that interactive learning platforms are an effective means of spreading knowledge that can enhance innovations in medicine.
“It is what we know already that often prevents us from learning.”Claude Bernard Physiologist